LB vs Ropivacaine for SPLS Recovery
Published: 12 March 2026| Version 1 | DOI: 10.17632/hdcm4pkk6w.1
Contributor:
Lingyu WangDescription
Supplemental files for The Journal of Minimally Invasive Gynecology manuscript
Files
Steps to reproduce
This randomized, double-blind trial was conducted at Guangzhou Women and Children's Medical Center (Oct 2024–Oct 2025). Eighty patients undergoing gynecologic single-port laparoscopic surgery were randomly assigned to receive periumbilical infiltration with either liposomal bupivacaine (266 mg/20 mL) or ropivacaine (0.2%/20 mL).QoR-15 score at 48 hours (primary outcome),Pain scores (NRS) at rest and during ambulation,opioid consumption and rescue analgesic use,adverse events, hospital stay, and patient satisfaction were recorded
Institutions
- Guangzhou Women and Children Medical CenterGuangdong, Guangzhou
Categories
Analgesia, Anesthesia